University Hospital Basel / Tumour Centre
Basel's university hospital in the home city of Roche and Novartis, with strong tumour immunology, radiopharmaceutical and breast metastasis research.
The Tumour Centre of University Hospital Basel coordinates cancer care in a city that is also headquarters to Roche and Novartis and home to the Friedrich Miescher Institute and the University of Basel's Department of Biomedicine. Alfred Zippelius and Heinz Läubli lead tumour immunology and early-phase immunotherapy trials, Mohamed Bentires-Alj studies breast cancer metastasis, Viola Heinzelmann-Schwarz heads gynaecological oncology, and the nuclear medicine and radiopharmaceutical chemistry groups (Damian Wild, Melpomeni Fani) develop novel peptide radioligands, including exendin-based imaging of insulinomas. The hospital runs haematology and CAR-T, thoracic and visceral surgery, and radiotherapy, and hosts SAKK and pharma-sponsored trials.
- Tumour immunology and early-phase immunotherapy
- Radiopharmaceutical chemistry
- Breast cancer metastasis research
- Gynaecological oncology
- Haematology and CAR-T
Pages like this
not linked directly; found by shared links- InstitutionKing Hussein Cancer Center
Shares PET/CT, Radioligand therapy (beta emitters), HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.
- ProductGallium-68 DOTATATE (and Cu-64 DOTATATE)
Shares PET/CT, Novartis, Neuroendocrine tumours, Radioligand therapy (beta emitters).
- InstitutionErasmus MC Cancer Institute
Shares PET/CT, Novartis, Neuroendocrine tumours, Radioligand therapy (beta emitters).
- Key paperNETTER-2: lutetium-177 dotatate as first treatment for higher-grade gastroenteropancreatic neuroendocrine tumours
Shares PET/CT, Novartis, Neuroendocrine tumours, Radioligand therapy (beta emitters).
- InstitutionHenan Cancer Hospital
Shares CAR-T cell therapy, Immune checkpoint inhibitors, Non-small-cell lung cancer.
- InstitutionHealthCare Global Enterprises
Shares PET/CT, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.
- IdeaTreat the body cavity, not the bloodstream, for surface spread
Shares Metastasis is understood least and studied last, Ovarian cancer, CAR-T cell therapy, Immune checkpoint inhibitors.
- IdeaBlunt the inflammation that wakes sleeping cancer cells
Shares Metastasis is understood least and studied last, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.